Abstract
Saudi Arabia has a well-developed national medicine policy as well as a well-established drug regulatory framework. Moreover, there is a well-defined pharmaceutical pricing policy, and the medicine prices are strictly controlled. The Saudi Pharmaceutical market is the largest market in the Middle East and African (MEA) region. Moreover, it is heavily dependent on imported medicines and dominated by patented and original medicines. Regarding rational use of medicines, there are several issues that need to be addressed. These include unrestricted access to medicines in the community pharmacies. Moreover, the involvement of community pharmacists in promoting rational use of medicines is currently limited. Additionally, generic medicines are still underutilized in the healthcare system. The way forward is the full implementation of these policies and the stricter enforcement of the laws governing medicines sales and dispensing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Central Department of Statistics and Information (CDSI), Kingdom of Saudi Arabia. (2015). Facts about the kingdom [Online]. Available: http://www.cdsi.gov.sa/socandpub/resd. Accessed 8 Dec 2015.
Ministry of Foreign Affairs, Kingdom of Saudi Arabia. (2006). About Saudi Arabia [Online]. Available: http://www.mofa.gov.sa/sites/mofaen/ServicesAndInformation/aboutKingDom/Pages/KingdomGeography46466.aspx. Accessed 10 Dec 2015.
High Commission of Development of Arriyadh. (2013). About Riyadh [Online]. Available: http://www.arriyadh.com/Eng/ab-arriyad/index.aspx/?1=1&menuId=4701. Accessed 12 Dec 2015.
World Health Organization (WHO). (2007). Saudi Arabia: Country cooperation strategy at a glance [Online]. Available: http://www.who.int/countryfocus/cooperation_strategy/ccsbrief_sau_en.pdf. Accessed 9 Dec 2015.
Khaliq, A. (2012). The Saudi health care system: A view from the minaret. World Health & Population, 13(3), 52–64.
Almalki, M., Fitzgerald, G., & Clark, M. (2011). Health care system in Saudi Arabia: An overview. Eastern Mediterranean Health Journal, 17(10), 784–793.
The Spanish National Research Council (CSIC). (2013). Ranking web of hospitals- Middle East [Online]. Available: http://hospitals.webometrics.info/en/Asia_Pacifico/Middle_East. Accessed 30 June 2016.
Saudi Ministry of Health (2009). Saudi national strategy of healthcare services [Online]. Available: http://www.chs.gov.sa/_layouts/CareStrategy/health.pdf. accessed 02 March 2017.
Walston, S., Al-Harbi, Y., & Al-Omar, B. (2008). The changing face of healthcare in Saudi Arabia. Annals of Saudi Medicine, 28(4), 243–250.
Regional Health Systems Observatory, the Eastern Mediterranean Regional Office (EMRO), World Health Organization (WHO). (2006). Health systems profile- Saudi Arabia [Online]. Available: http://apps.who.int/medicinedocs/documents/s17308e/s17308e.pdf. Accessed 9 Dec 2015.
Saudi Ministry of Health. (2008). Health statistics book year [Online]. Available: http://www.moh.gov.sa/Ministry/Statistics/book/Pages/default.aspx. Accessed 4 Dec 2015.
Saudi Ministry of Health. (2014). Health statistics book year [Online]. Available at: http://www.moh.gov.sa/Ministry/Statistics/book/Documents/1435.pdf. Accessed 04 Dec 2015.
Saudi Ministry of Health. (2009). Health statistics book year [Online]. Available: http://www.moh.gov.sa/Ministry/Statistics/book/Pages/default.aspx . Accessed 4 Dec 2015.
Business Monitor International (BMI). (2015). Saudi Arabia pharmaceuticals & healthcare report Q3 2015. London, UK: Business Monitor International Ltd.
World Health Organization (WHO) (2015). Saudi Arabia national expenditure on health [Online]. Available: http://apps.who.int/nha/database/Key_Indicators_by_Country/Index/en. Accessed 12 Dec 2015.
Saudi Ministry of Health. (2011). Health statistical book year [Online]. Available: http://www.moh.gov.sa/Ministry/Statistics/book/Pages/default.aspx. Accessed 4 Dec 2015.
Business Monitor International (BMI). (2015). United Arab Emirates pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.
Business Monitor International (BMI). (2015). Kuwait pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.
Business Monitor International (BMI). (2015). Qatar pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.
Business Monitor International (BMI). (2015). Oman pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.
Business Monitor International (BMI). (2015). Bahrain pharmaceuticals & healthcare report Q3. London, UK: Business Monitor International Ltd.
Business Monitor International (BMI). (2013). Saudi Arabia pharmaceuticals & healthcare report Q2. London, UK: Business Monitor International Ltd.
Saudi Food and Drug Authority (SFDA). (2013). About SFDA [Online]. Available at: http://www.sfda.gov.sa/en/about/Pages/overview.aspx. Accessed 12 Dec 2015.
Saudi Food and Drug Authority (SFDA)/World Health Organization (WHO).( 2012). Saudi Arabia pharmaceutical country profile. Available at: http://www.who.int/medicines/areas/coordination/Saudi_ArabiaPSCP_Narrative2012-04-18_Final.pdf . Accessed 12 Dec 2015.
Executive Board of the Health Ministers’ Council for GCC States. (2014). The GCC data requirements for human drugs submission content of the dossier version 1.3 [Online]. Available: https://www.sfda.gov.sa/ar/drug/resources/DocLib2/The%20GCC%20Data%20Requirements%20for%20Human%20Drugs%20Submission%20version%201.3%20GCC%202014.pdf. Accessed 13 Dec 2015.
Saudi Food & Drug Authority (SFDA). (2014). Regulatory framework for drug approvals (version 5) [Online]. Available: http://www.sfda.gov.sa/en/drug/drug_reg/Regulations/Regulatory_Framework_for_Drug_Approvals_v_5%200.pdf. Accessed 12 Dec 2015.
Tantash, M. (2012). Middle East generics: Challenges & opportunities. The Journal of Gene Medicine, 9(1), 13–20.
Saudi Food and Drug Authority (SFDA). (2011). Registration requirements for drug companies and manufacturers [Online]. Available: http://www.sfda.gov.sa/ar/drug/resources/DocLib2/%D8%A3%D8%B3%D8%B3%D9%88%D9%85%D8%AA%D8%B7%D9%84%D8%A8%D8%A7%D8%AA%D9%88%D8%B4%D8%B1%D9%88%D8%B7%D8%A7%D9%84%D8%AA%D8 %B3%D8%AC%D9%8A%D9%84.doc. Accessed 2 Aug 2014.
Saudi Food and Drug Authority (SFDA). (2016). Guidelines and regulations. Available at: http://www.sfda.gov.sa/en/drug/drug_reg/Pages/default.aspx?news=Main. Accessed 30 June 2016.
Pharmacy, Pharmaceutical Institutions and Pharmaceuticals Act (2005 in Arabic). Riyadh. Saudi Arabia. Available at: http://www.moh.gov.sa/depts/Licenses/Documents/002.pdf. Accessed 30 June 2016.
Saudi Food and Drug Authority (SFDA). (2013). The rules for pricing of medicines. Available at: https://www.sfda.gov.sa/AR/DRUG/DRUG_REG/Pages/drug_reg.aspx. Accessed on 13 Jan 2017.
Alnutafy, F. S. (2009). Economic analysis of the prices of generic drugs in Saudi Arabia: Are the prices of generics too high? MSc thesis: The University of Queensland, Australia.
Saudi Food and Drug Authority (SFDA). (2015). Official list of registered drugs and herbal products-2015 Available at: http://www.sfda.gov.sa/ar/drug/search/Pages/default.aspx. Accessed 10 Dec 2015.
Bawazir, S. A., Alkudsi, M. A., Al Humaidan, A. S., Al Jaser, M. A., & Sasich, L. D. (2013). Pharmaceutical policies used by private health insurance companies in Saudi Arabia. Saudi Pharmaceutical Journal, 21(3), 267–276.
Cooperative Health Act. (1999). Riyadh. Saudi Arabia.
Cooperative Health Insurance Policy (amended). (2009). Riyadh. Saudi Arabia.
Health Professions Practice Act. (2005). Riyadh. Saudi Arabia.
National Unified Procurement Company (NUPCO). (2016). About NUPCO [Online]. Available: http://www.nupco.com/web/en/about-nupco. Accessed 20 Mar 2016.
The Saudi Center for Evidence Based Healthcare (EBHC). (2015). About Us. Available at: http://www.moh.gov.sa/endepts/Proofs/Pages/Definition.aspx. Accessed 12 Dec 2015.
World Health Organization (WHO) (2001). How to develop and implement a national drug policy [Online]. Available: http://apps.who.int/medicinedocs/en/d/Js2283e/. Accessed 13 Dec 2015.
Cameron, A., Mantel-Teeuwisse, A. K., Leufkens, H. G. M., & Laing, R. O. (2012). Switching from originator brand medicines to generic equivalents in selected developing countries: How much could be saved? Value in Health, 15(5), 664–673.
Godman, B., Shrank, W., Wettermark, B., Andersen, M., Bishop, I., Burkhardt, T., Garuolienè, K., Kalaba, M., Laius, O., Joppi, R., Sermet, C., Schwabe, U., Teixeira, I., Tulunay, F. C., Wendykowska, K., Zara, C., & Gustafsson, L. L. (2010). Use of generics—a critical cost containment measure for all healthcare professionals in Europe? Pharmaceuticals, 3(8), 2470–2494.
Cameron, A., Ewen, M., Ross-Degnan, D., Ball, D., & Laing, R. (2009). Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis. The Lancet, 373(9659), 240–249.
Executive Regulations of Health Professions Practice Act. (2006). Riyadh. Saudi Arabia.
Albadr, Y., & Khan, T. M. (2015). Factors influencing community pharmacist decision to dispense generic or branded medicines; Eastern Province, Alahsa. Saudi Arabia. Saudi Pharmaceutical Journal, 23(2), 143–146.
Alrasheedy, A. A., Hassali, M. A., Aljadhey, H., Ibrahim, M. I. M., AL-Tamimi, S. K. (2013). A qualitative exploration of generic substitution practice of community pharmacists in Riyadh, Saudi Arabia. 1st National Conference on Quality Use of Medicine. Selangor, Malaysia.
Salhia, H. O., Ali, A., Rezk, N. L., & El Metwally, A. (2015). Perception and attitude of physicians toward local generic medicines in Saudi Arabia: A questionnaire-based study. Saudi Pharmaceutical Journal, 23(4), 397–404.
Albarraq, A. (2013). Consumers’ perceptions on generic medicines in Taif city, Saudi Arabia. Saudi Journal for Health Sciences, 2(1), 18–22.
Al-Hassan, M. (2009). A look at community pharmacy practice in Saudi Arabia. Research Journal of Medical Sciences, 3(3), 111–114.
Najjar, T. A. (2001). A survey on community pharmacies in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal, 9(2), 113–118.
Bawazir, S. A. (2004). Consumer attitudes towards community pharmacy services in Saudi Arabia. The International Journal of Pharmacy Practice, 12(2), 83–89.
Khan, T. M., & Ibrahim, Y. (2013). A qualitative exploration of the non-prescription sale of drugs and incidence of adverse events in community pharmacy settings in the eastern province of the Kingdom of Saudi Arabia. European Journal of Hospital Pharmacy, 20(1), 26–31.
Abdulhak, A. B., Al Tannir, M., Almansor, M., Almohaya, M., Onazi, A., Marei, M., Aldossary, O., Obeidat, S., Obeidat, M., & Riaz, M. (2011). Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: A cross sectional study. BMC Public Health, 11(1), 538.
Al-Freihi, H., Ballal, S. G., Jaccarini, A., Young, M. S., Abdul-Cader, Z., & El Mouzan, M. (1987). Potential for drug misuse in the eastern province of Saudi Arabia. Annals of Saudi Medicine, 7, 301–305.
Al-Ghamdi, M. S. (2001). Empirical treatment of uncomplicated urinary tract infection by community pharmacist in the eastern province of Saudi Arabia. Saudi Medical Journal, 22(12), 1105–1108.
Al-Mohamadi, A., Badr, A., Bin Mahfouz, L., Samargandi, D., & Al, A. A. (2013). Dispensing medications without prescription at Saudi community pharmacy: Extent and perception. Saudi Pharmaceutical Journal, 21(1), 13–18.
Bawazir, S. (1992). Prescribing pattern at community pharmacies in Saudi Arabia. International Pharmacy Journal, 6(5), 222–224.
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014). Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. The Lancet Infectious Diseases, 14(8), 742–750.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Alrasheedy, A.A., Hassali, M.A., Wong, Z.Y., Aljadhey, H., AL-Tamimi, S.K., Saleem, F. (2017). Pharmaceutical Policy in Saudi Arabia. In: Babar, ZUD. (eds) Pharmaceutical Policy in Countries with Developing Healthcare Systems. Adis, Cham. https://doi.org/10.1007/978-3-319-51673-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-51673-8_16
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-51672-1
Online ISBN: 978-3-319-51673-8
eBook Packages: MedicineMedicine (R0)